5407162025-04-012025-06-305407162025-06-305407162025-04-015407162025-04-012025-06-30in-capmkt:OtherIncome1Member5407162025-04-012025-06-30in-capmkt:OtherIncome2Member5407162025-04-012025-06-30in-capmkt:OtherIncome3Member5407162025-04-012025-06-30in-capmkt:OtherIncome4Member5407162025-04-012025-06-30in-capmkt:OtherOperatingExpenses1Member5407162025-04-012025-06-30in-capmkt:ShareholdersAccountOtherIncome1Member5407162025-04-012025-06-30in-capmkt:FireMember5407162025-04-012025-06-30in-capmkt:MarineMember5407162025-04-012025-06-30in-capmkt:HealthIncludingPersonalAccidentMember5407162025-04-012025-06-30in-capmkt:HealthRetailMember5407162025-04-012025-06-30in-capmkt:HealthGroupMember5407162025-04-012025-06-30in-capmkt:HealthGovernmentSchemesMember5407162025-04-012025-06-30in-capmkt:MotorMember5407162025-04-012025-06-30in-capmkt:RetailMember5407162025-04-012025-06-30in-capmkt:GroupAndCorporateMember5407162025-04-012025-06-30in-capmkt:OtherReportableSegments1Member5407162025-04-012025-06-30in-capmkt:FireMember5407162025-04-012025-06-30in-capmkt:MarineMember5407162025-04-012025-06-30in-capmkt:HealthIncludingPersonalAccidentMember5407162025-04-012025-06-30in-capmkt:HealthRetailMember5407162025-04-012025-06-30in-capmkt:HealthGroupMember5407162025-04-012025-06-30in-capmkt:HealthGovernmentSchemesMember5407162025-04-012025-06-30in-capmkt:MotorMember5407162025-04-012025-06-30in-capmkt:RetailMember5407162025-04-012025-06-30in-capmkt:GroupAndCorporateMember5407162025-04-012025-06-30in-capmkt:OtherReportableSegments1Member5407162025-04-012025-06-30in-capmkt:FireMember5407162025-04-012025-06-30in-capmkt:MarineMember5407162025-04-012025-06-30in-capmkt:HealthIncludingPersonalAccidentMember5407162025-04-012025-06-30in-capmkt:HealthRetailMember5407162025-04-012025-06-30in-capmkt:HealthGroupMember5407162025-04-012025-06-30in-capmkt:HealthGovernmentSchemesMember5407162025-04-012025-06-30in-capmkt:MotorMember5407162025-04-012025-06-30in-capmkt:RetailMember5407162025-04-012025-06-30in-capmkt:GroupAndCorporateMember5407162025-04-012025-06-30in-capmkt:OtherReportableSegments1Member5407162025-04-012025-06-30in-capmkt:FireMember5407162025-04-012025-06-30in-capmkt:MarineMember5407162025-04-012025-06-30in-capmkt:HealthIncludingPersonalAccidentMember5407162025-04-012025-06-30in-capmkt:HealthRetailMember5407162025-04-012025-06-30in-capmkt:HealthGroupMember5407162025-04-012025-06-30in-capmkt:HealthGovernmentSchemesMember5407162025-04-012025-06-30in-capmkt:MotorMember5407162025-04-012025-06-30in-capmkt:RetailMember5407162025-04-012025-06-30in-capmkt:GroupAndCorporateMember5407162025-04-012025-06-30in-capmkt:OtherReportableSegments1Member5407162025-06-30in-capmkt:FireMember5407162025-06-30in-capmkt:MarineMember5407162025-06-30in-capmkt:HealthIncludingPersonalAccidentMember5407162025-06-30in-capmkt:HealthRetailMember5407162025-06-30in-capmkt:HealthGroupMember5407162025-06-30in-capmkt:HealthGovernmentSchemesMember5407162025-06-30in-capmkt:MotorMember5407162025-06-30in-capmkt:RetailMember5407162025-06-30in-capmkt:GroupAndCorporateMember5407162025-06-30in-capmkt:OtherReportableSegments1Member5407162025-04-012025-06-30in-capmkt:OtherReportableSegments1Member5407162025-06-30in-capmkt:FireMember5407162025-06-30in-capmkt:MarineMember5407162025-06-30in-capmkt:HealthIncludingPersonalAccidentMember5407162025-06-30in-capmkt:HealthRetailMember5407162025-06-30in-capmkt:HealthGroupMember5407162025-06-30in-capmkt:HealthGovernmentSchemesMember5407162025-06-30in-capmkt:MotorMember5407162025-06-30in-capmkt:RetailMember5407162025-06-30in-capmkt:GroupAndCorporateMember5407162025-06-30in-capmkt:OtherReportableSegments1Member5407162025-04-012025-06-30in-capmkt:OtherReportableSegments1Member5407162025-04-012025-06-30

AuditorDomain1

5407162025-04-012025-06-30

AuditorDomain2

iso4217:INRxbrli:pureiso4217:INRxbrli:sharesxbrli:shares

540716

ICICIGI

INE765G01017

ICICI LOMBARD GENERAL INSURANCE COMPANY LIMITED

Main Board

Equity

Non-Linked Policy

2025-04-01

2026-03-31

2025-07-15

2025-06-25

INR

Lakhs

Quarterly

First quarter

2025-07-15

14:45:00

2025-07-15

17:25:00

Declaration of unmodified opinion

false

Not Applicable

2025-04-01

2025-06-30

Audited

Standalone

80525500000

56105200000

51360900000

9427400000

45300000

60833600000

9407500000

4308500000

3075300000

7383800000

29105400000

8395600000

37501000000

54292300000

-2931400000

6541300000

3167400000

84400000

9793100000

140000000

600000

-284600000

-144000000

9937100000

2466300000

7470800000

700000

64117000000

71587800000

4966400000

143272200000

13257900000

143043400000

411490100000

554533500000

-392979900000

161553600000

0.027

0.278

0.73

0.697

1.029

15.06

232000

360000

241085490

0.4854

In the General Information Sheet: 1. We have mentioned NSE Symbol as "ICICI" instead of "ICICIGI" as by mentioning ICICIGI the sheet was not validating. 2. ICICI Lombard is General Insurance Company and hence type of insurance viz. “Linked and Non-Linked Policy” would not be applicable. However, in order to validate the sheet we have selected type of insurance as “Non-Linked Policy” 1(ii). Net of reinsurance (Including Excess of Loss Reinsurance). 1(iv). Including capital gains, net of amortisation and losses. 2(i) & (ii). Commission is net of commission received on reinsurance cession. 8(a). Dividend is recognised in the period it is approved as prescribed by MCA. Analytical ratios have been calculated as per definition given in IRDAI analytical ratios disclosures. Analytical ratios (i):- The Solvency has been computed at the last day of the period. Analytical ratios (ii):- The Expenses of Management has been computed on the basis of Gross Direct Premium Analytical ratios (v):- The Ratio has been computed at the last day of the period. Analytical ratios (vi) & (viii):- Not annualised Analytical ratios (viii):- Excludes unrealised gains or losses on real estate and unlisted equity Analytical ratios (viii):- Yield on investments with unrealised gains is computed using the modified Dietz method Analytical ratios (viii)(a):- The computation is based on time weighted average book value. Analytical ratios (vi)(a)&(b):- Earnings Per Share Basic: Rs. 15.06 Diluted: Rs. 14.92 (Current Quarter)

Foreign exchange gain / (loss)

-5300000

Towards remuneration of MD/CEO/WTD/Other KMPs

19500000

Contribution from Shareholders Funds towards excess EOM

Miscellaneous Income

31100000

Other Expenses

3075300000

Other income

84400000

1416800000

566800000

300000

1448400000

140100000

-5600000

4509400000

375500000

3800000

14340300000

1108500000

27900000

20300000

3800000

26749000000

6536400000

19000000

302500000

83000000

200000

2523300000

548900000

-300000

Crop

50900000

64400000

Crop

548000000

-292200000

-1224900000

-1029900000

-4400000

-1060400000

50800000

122900000

Crop

-41300000

1115100000

-157700000

-845600000

106400000

-400000

5495000000

134100000

671400000

Crop

23000000

5495100000

2298100000

10664100000

31829200000

28900000

53092400000

2706900000

8426200000

Crop

100000

35690900000

10661100000

4548600000

17699400000

837700000

211602600000

1104600000

36462800000

Crop

15252400000

1 The above audited financial results of the ICICI Lombard General Insurance Company Limited (the Company) for the quarter ended June 30, 2025 were reviewed and recommended by the Audit Committee and subsequently approved by the Board of Directors at its Meeting held on July 15, 2025. 2 The above audited financial results were audited by the joint statutory auditors, Walker Chandiok & Co LLP, Chartered Accountants and PKF Sridhar & Santhanam LLP, Chartered Accountants who have issued an unmodified opinion on these financial results. 3 During the quarter ended June 30, 2025, the Company has allotted 909,691 equity shares of face value of Rs. 10 each pursuant to exercise of employee stock options granted. (For the quarter ended June 30, 2024, 536,708 equity Shares were allotted, for the quarter and year ended March 31, 2025, 492,015 equity shares and 3,041,182 equity shares respectively were allotted) 4 The shareholders had approved a final dividend of Rs. 7.00 per equity share of face value of Rs. 10 each for the year ended March 31, 2025 at the Annual General Meeting held on June 30, 2025. 5 In accordance with the IRDAI (Actuarial, Finance and Investment Functions of Insurers) Regulation, 2024 and Master Circular thereon dated May 17, 2024, with effect from October 1, 2024 the Company has given effect to recognise gross written premium on a 1/n basis where "n" denotes the policy duration and commissions paid only on such recorded gross written premium for applicable long-term products. This has resulted in a decrease in Gross Premium Written by Rs 31,975 lakhs (decrease in Gross Premiums written has no resultant impact on Operating Profit) respectively for the quarter ended June 30, 2025, also resulted in decrease of commissions & Brokerage (net) by Rs 1,738 lakhs respectively for the quarter ended June 30, 2025. This resulted in an increase in the Operating Profit/(Loss) by Rs 1,738 lakhs for the quarter ended June 30, 2025 along with increase in Profit / (Loss) after tax Rs 1,307 lakhs for the quarter ended June 30, 2025. 6 "Figures of the previous period have been re-grouped wherever necessary, to conform to the current year presentation." 7 In view of the seasonality of Industry, the financial results for the quarters are not indicative of full year's expected performance. 8 In accordance with requirements of IRDAI circular no. IRDAI/F&A/CIR/MISC/256/09/2021 dated September 30, 2021 on Public Disclosures by Insurers, the Company will publish the financials on the company's website latest by August 14, 2025.

Audited

true

PKF Sridhar and Santhanam LLP

true

2025-10-31

Walker Chandiok & Co LLP

true

2028-05-31